BrainStorm Cell Therapeutics Inc (BCLI):企業の財務・戦略的SWOT分析

◆英語タイトル:BrainStorm Cell Therapeutics Inc (BCLI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH42156FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy platform NurOwn, customized for the treatment of multiple sclerosis, amyotrophic lateral sclerosis, parkinson’s disease, huntington’s disease, autism spectrum disorder, peripheral nerve injury, and other indications. Its proprietary technology NurOwn induces mesenchymal stem cells to secrete high levels of neurotrophic factors to promote the survival of neurons. The company has operations in the US and Israel. BrainStorm Cell Therapeutics is headquartered in New York, the US.

BrainStorm Cell Therapeutics Inc Key Recent Developments

Feb 04,2021: BrainStorm announces full year 2020 financial results and provides a corporate update
Jan 28,2021: BrainStorm-Cell Therapeutics to Announce Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update
Oct 22,2020: Catalent and BrainStorm Cell Therapeutics announce partnership for the manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn
Oct 15,2020: BrainStorm announces financial results for the third quarter of 2020 and provides a corporate update
Sep 29,2020: BrainStorm appoints William K. White as senior vice president, head of market access & pricing

This comprehensive SWOT profile of BrainStorm Cell Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BrainStorm Cell Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

BrainStorm Cell Therapeutics Inc – Key Information
BrainStorm Cell Therapeutics Inc – Overview
BrainStorm Cell Therapeutics Inc – Key Employees
BrainStorm Cell Therapeutics Inc – Key Employee Biographies
BrainStorm Cell Therapeutics Inc – Key Operational Heads
BrainStorm Cell Therapeutics Inc – Major Products and Services
BrainStorm Cell Therapeutics Inc – History
BrainStorm Cell Therapeutics Inc – Company Statement
BrainStorm Cell Therapeutics Inc – Locations And Subsidiaries
BrainStorm Cell Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

BrainStorm Cell Therapeutics Inc – Business Description
BrainStorm Cell Therapeutics Inc – Corporate Strategy
BrainStorm Cell Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
BrainStorm Cell Therapeutics Inc – Strengths
BrainStorm Cell Therapeutics Inc – Weaknesses
BrainStorm Cell Therapeutics Inc – Opportunities
BrainStorm Cell Therapeutics Inc – Threats
BrainStorm Cell Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

BrainStorm Cell Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

BrainStorm Cell Therapeutics Inc, Key Information
BrainStorm Cell Therapeutics Inc, Key Ratios
BrainStorm Cell Therapeutics Inc, Share Data
BrainStorm Cell Therapeutics Inc, Major Products and Services
BrainStorm Cell Therapeutics Inc, History
BrainStorm Cell Therapeutics Inc, Key Employees
BrainStorm Cell Therapeutics Inc, Key Employee Biographies
BrainStorm Cell Therapeutics Inc, Key Operational Heads
BrainStorm Cell Therapeutics Inc, Other Locations
BrainStorm Cell Therapeutics Inc, Subsidiaries
BrainStorm Cell Therapeutics Inc, Key Competitors
BrainStorm Cell Therapeutics Inc, SWOT Analysis
BrainStorm Cell Therapeutics Inc, Ratios based on current share price
BrainStorm Cell Therapeutics Inc, Annual Ratios
BrainStorm Cell Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[BrainStorm Cell Therapeutics Inc (BCLI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • British Broadcasting Corporation:企業の戦略・SWOT・財務分析
    British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report Summary British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bank of Baroda:企業の戦略・SWOT・財務情報
    Bank of Baroda - Strategy, SWOT and Corporate Finance Report Summary Bank of Baroda - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tufts Medical Center-医療機器分野:企業M&A・提携分析
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • Vigor Shipyards, Inc:企業の戦略・SWOT・財務分析
    Vigor Shipyards, Inc - Strategy, SWOT and Corporate Finance Report Summary Vigor Shipyards, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Infineum International Ltd:企業の戦略的SWOT分析
    Infineum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Landesbank Berlin Holding Ag
    Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report Summary Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Energy Development Corp (EDC):電力:M&Aディール及び事業提携情報
    Summary Energy Development Corp (EDC), formerly Philippine National Oil Company, is a diversified renewable energy company. The company explores, develops, operates and utilizes geothermal energy and other indigenous renewable energy projects in the Philippines. EDC by utilizing geothermal energy an …
  • Fortis Healthcare Ltd (FORTIS):企業の財務・戦略的SWOT分析
    Fortis Healthcare Ltd (FORTIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Fugro GeoServices Ltd:企業の戦略的SWOT分析
    Fugro GeoServices Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Transaero Inc:企業の戦略・SWOT・財務情報
    Transaero Inc - Strategy, SWOT and Corporate Finance Report Summary Transaero Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kyowa Hakko Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析
    Kyowa Hakko Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Cyanotech Corp
    Cyanotech Corp - Strategy, SWOT and Corporate Finance Report Summary Cyanotech Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Zafgen Inc (ZFGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …
  • AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析
    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AcuFocus Inc:医療機器:M&Aディール及び事業提携情報
    Summary AcuFocus Inc (AcuFocus) is an ophthalmic medical device company that develops and markets technologies for the improvement of near vision. The company develops and markets breakthrough technologies for the improvement of vision. It’s IC-8 IOL, a small aperture lens that is designed for preby …
  • Total SA (FP):企業の財務・戦略的SWOT分析
    Total SA (FP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Amyris Inc (AMRS):企業の財務・戦略的SWOT分析
    Summary Amyris Inc (Amyris) formerly Amyris Biotechnologies Inc, is a healthcare product manufacturer that offers integrated renewable products. The company provides alternatives to a range of petroleum-sourced products and rare materials. It offers health and wellness products, clean beauty product …
  • B. Braun Medical Inc-医療機器分野:企業M&A・提携分析
    Summary B. Braun Medical Inc (B. Braun), a subsidiary of B. Braun Melsungen AG is a medical device company that provides infusion therapy and pain management technology, products and services. The company’s product portfolio includes TPN compounding bags, parenteral nutrition additives, closed syste …
  • RIKEN:製薬・医療:M&Aディール及び事業提携情報
    Summary RIKEN is a research organization that carries out basic and applied science research programs. The organization’s research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, resear …
  • Nomura Research Institute Ltd (4307):企業の財務・戦略的SWOT分析
    Nomura Research Institute Ltd (4307) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆